Good morning :)
Place Order
Add to Watchlist

Balaxi Pharmaceuticals Ltd

BALAXI Share Price

49.860.22% (-0.11)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Health Care Equipment & Supplies
Smallcap

With a market cap of ₹275 cr, stock is ranked 2,258

High Risk

Stock is 3.69x as volatile as Nifty

BALAXI Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

Avg

Can be considered moderately valued vs the market

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care
Health Care Equipment & Supplies
Smallcap

With a market cap of ₹275 cr, stock is ranked 2,258

High Risk

Stock is 3.69x as volatile as Nifty

BALAXI Performance & Key Metrics

BALAXI Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
10.981.37—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.596.400.79%

BALAXI Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

BALAXI Company Profile

The company is engaged in wholesale trading of pharmaceuticals products, food products and builders’ hardware products. The Company offers a range of food and biscuit products under the brand name YAP.

Investor Presentation

View older View older 

Jun 7, 2025

PDF
View Older Presentations

BALAXI Similar Stocks (Peers)

Compare with peers Compare with peers 

BALAXI Similar Stocks (Peers)

Compare with peers Compare with peers 
Inventurus Knowledge Solutions Ltd
IKS
PE Ratio
54.35
54.35
1Y Return
16.64%
16.64%
Buy Reco %
25.00
25.00
Poly Medicure Ltd
POLYMED
PE Ratio
66.43
66.43
1Y Return
3.83%
3.83%
Buy Reco %
60.00
60.00
Laxmi Dental Ltd
LAXMIDENTL
PE Ratio
75.27
75.27
1Y Return
20.95%
20.95%
Buy Reco %
100.00
100.00
Tarsons Products Ltd
TARSONS
PE Ratio
68.69
68.69
1Y Return
22.80%
22.80%
Buy Reco %
80.00
80.00
Borosil Scientific Ltd
BOROSCI
PE Ratio
53.39
53.39
1Y Return
20.19%
20.19%
Buy Reco %
0.00
0.00
Compare with Peers

BALAXI Forecast

BALAXI Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

BALAXI

BALAXI

Income

Balance Sheet

Cash Flow

BALAXI Income Statement

BALAXI Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 44.27%, vs industry avg of 24.47%

Increasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 2.18% to 3.98%

Higher than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 32.71%, vs industry avg of 28.87%

Loading...

Financial YearFY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue14.4946.22233.56284.36339.07241.92288.84288.84
Raw Materialssubtract0.0032.83172.15195.60202.42128.68255.35255.34
Power & Fuel Costsubtract0.000.000.000.350.280.04
Employee Costsubtract0.902.108.4712.4728.9528.04
Selling & Administrative Expensessubtract0.591.754.7417.5642.2936.02
Operating & Other expensessubtract10.550.703.302.595.0842.27
Depreciation/Amortizationsubtract0.000.010.300.511.752.101.891.89
Interest & Other Itemssubtract0.000.050.280.761.382.772.932.94
Taxes & Other Itemssubtract0.472.696.196.8610.964.403.603.59
EPS1.301.877.639.539.11-0.464.544.60
DPS0.000.000.000.100.000.000.000.00
Payout ratio0.000.000.000.010.000.000.000.00
See Costs

BALAXI Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025FY 2025

Annual Report Pending

Investor Presentation

Jun 7PDF
Feb 13PDF
Nov 13PDF
FY 2024FY 2024

Annual Report Unavailable

Investor Presentation

Aug 3PDF
FY 2023FY 2023

Annual Report Unavailable

Investor Presentation

May 29PDF
Feb 1PDF
Nov 5PDF
+2 more
FY 2022FY 2022

Annual Report Unavailable

Investor Presentation

Jun 24PDF
 

BALAXI Stock Peers

BALAXI Past Performance & Peer Comparison

BALAXI Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareHealth Care Equipment & Supplies

Valuation

Technical

Forecast

ScreenerCompare valuation-basic on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Balaxi Pharmaceuticals Ltd10.981.37—
Inventurus Knowledge Solutions Ltd54.3522.81—
Poly Medicure Ltd66.4315.300.15%
Laxmi Dental Ltd75.2753.67—

BALAXI Stock Price Comparison

Compare BALAXI with any stock or ETF
Compare BALAXI with any stock or ETF
BALAXI
Loading...

BALAXI Holdings

BALAXI Shareholdings

BALAXI Promoter Holdings Trend

BALAXI Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

BALAXI Institutional Holdings Trend

BALAXI Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

BALAXI Shareholding Pattern

BALAXI Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding65.99%0.00%0.02%16.02%17.96%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

BALAXI Shareholding History

BALAXI Shareholding History

MarAprJunSepDec '24Mar17.08%17.08%16.88%16.48%16.48%16.02%

BALAXI Insider Trades & Bulk Stock Deals

BALAXI Insider Trades & Bulk Stock Deals

Loading...

smallcases containing BALAXI stock

smallcases containing BALAXI stock

Looks like this stock is not in any smallcase yet.

BALAXI Events

BALAXI Events

BALAXI Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

BALAXI Dividend Trend

No dividend trend available

BALAXI Upcoming Dividends

BALAXI Upcoming Dividends

No upcoming dividends are available

BALAXI Past Dividends

BALAXI Past Dividends

Cash Dividend

Ex DateEx DateJul 1, 2022

Final
Final | Div/Share: ₹0.50

Dividend/Share

₹0.50

Ex DateEx Date

Jul 1, 2022

BALAXI Stock News & Opinions

BALAXI Stock News & Opinions

Corporate
Balaxi Pharmaceuticals AGM scheduled

Balaxi Pharmaceuticals announced that the 82th Annual General Meeting(AGM) of the company will be held on 25 August 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Balaxi Pharmaceuticals consolidated net profit declines 20.95% in the March 2025 quarter

Net profit of Balaxi Pharmaceuticals declined 20.95% to Rs 8.64 crore in the quarter ended March 2025 as against Rs 10.93 crore during the previous quarter ended March 2024. Sales rose 27.48% to Rs 76.27 crore in the quarter ended March 2025 as against Rs 59.83 crore during the previous quarter ended March 2024. For the full year,net profit declined 30.19% to Rs 25.07 crore in the year ended March 2025 as against Rs 35.91 crore during the previous year ended March 2024. Sales rose 21.25% to Rs 292.56 crore in the year ended March 2025 as against Rs 241.29 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales76.2759.83 27 292.56241.29 21 OPM %16.4522.51 -12.7219.37 - PBDT10.1211.07 -9 30.5642.41 -28 PBT9.6610.40 -7 28.6740.31 -29 NP8.6410.93 -21 25.0735.91 -30 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Balaxi Pharmaceuticals to convene board meeting

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Balaxi Pharmaceuticals consolidated net profit declines 60.56% in the December 2024 quarter

Net profit of Balaxi Pharmaceuticals declined 60.56% to Rs 5.36 crore in the quarter ended December 2024 as against Rs 13.59 crore during the previous quarter ended December 2023. Sales rose 20.56% to Rs 73.29 crore in the quarter ended December 2024 as against Rs 60.79 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales73.2960.79 21 OPM %5.4422.47 - PBDT6.5513.11 -50 PBT6.0712.63 -52 NP5.3613.59 -61 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Balaxi Pharmaceuticals to convene board meeting

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 February 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
Balaxi Pharmaceuticals consolidated net profit declines 68.19% in the September 2024 quarter

Net profit of Balaxi Pharmaceuticals declined 68.19% to Rs 4.59 crore in the quarter ended September 2024 as against Rs 14.43 crore during the previous quarter ended September 2023. Sales rose 41.41% to Rs 77.38 crore in the quarter ended September 2024 as against Rs 54.72 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales77.3854.72 41 OPM %13.6919.66 - PBDT6.0310.67 -43 PBT5.5610.01 -44 NP4.5914.43 -68 Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Balaxi Pharmaceuticals announces board meeting date

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November 2024Powered by Capital Market - Live

8 months agoCapital Market - Live
Earnings
Balaxi Pharmaceuticals reports consolidated net profit of Rs 6.48 crore in the June 2024 quarter

Net profit of Balaxi Pharmaceuticals reported to Rs 6.48 crore in the quarter ended June 2024 as against net loss of Rs 41.34 crore during the previous quarter ended June 2023. Sales declined 0.52% to Rs 65.62 crore in the quarter ended June 2024 as against Rs 65.96 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales65.6265.96 -1 OPM %15.3813.40 - PBDT7.877.54 4 PBT7.377.26 2 NP6.48-41.34 LP Powered by Capital Market - Live

11 months agoCapital Market - Live
Corporate
Balaxi Pharmaceuticals to conduct AGM

Balaxi Pharmaceuticals announced that the 81st Annual General Meeting(AGM) of the company will be held on 23 August 2024.Powered by Capital Market - Live

11 months agoCapital Market - Live
Corporate
Balaxi Pharmaceuticals to convene board meeting

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2 August 2024.Powered by Capital Market - Live

11 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Balaxi Pharmaceuticals Ltd (BALAXI) today?

    The share price of BALAXI as on 10th July 2025 is ₹49.86. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Balaxi Pharmaceuticals Ltd (BALAXI) share?

    The past returns of Balaxi Pharmaceuticals Ltd (BALAXI) share are
    • Past 1 week: 0.85%
    • Past 1 month: -12.18%
    • Past 3 months: -25.30%
    • Past 6 months: -30.88%
    • Past 1 year: -55.90%
    • Past 3 years: -31.20%
    • Past 5 years: 99.44%

  3. What are the peers or stocks similar to Balaxi Pharmaceuticals Ltd (BALAXI)?

    The peers or stocks similar to Balaxi Pharmaceuticals Ltd (BALAXI) include:

  4. What is the market cap of Balaxi Pharmaceuticals Ltd (BALAXI) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Balaxi Pharmaceuticals Ltd (BALAXI) is ₹275.26 Cr as of 10th July 2025.

  5. What is the 52 week high and low of Balaxi Pharmaceuticals Ltd (BALAXI) share?

    The 52-week high of Balaxi Pharmaceuticals Ltd (BALAXI) is ₹129.44 and the 52-week low is ₹48.53.

  6. What is the PE and PB ratio of Balaxi Pharmaceuticals Ltd (BALAXI) stock?

    The P/E (price-to-earnings) ratio of Balaxi Pharmaceuticals Ltd (BALAXI) is 10.98. The P/B (price-to-book) ratio is 1.37.

  7. Which sector does Balaxi Pharmaceuticals Ltd (BALAXI) belong to?

    Balaxi Pharmaceuticals Ltd (BALAXI) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.

  8. How to buy Balaxi Pharmaceuticals Ltd (BALAXI) shares?

    You can directly buy Balaxi Pharmaceuticals Ltd (BALAXI) shares on Tickertape. Simply sign up, connect your demat account and place your order.